Companies: 10,638     total market cap: NZ$233.372 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novartis
NVS
#57
Rank
NZ$434.71 B
Marketcap
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Country
NZ$226.56
Share price
0.65%
Change (1 day)
35.41%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$108.14 Billion

According to Novartis's latest financial reports the company's total liabilities are NZ$108.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novartis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$103.05 B22.52%
2023-12-31NZ$84.11 B-7.97%
2022-12-31NZ$91.40 B-2.41%
2021-12-31NZ$93.65 B-4.97%
2020-12-31NZ$98.55 B5.66%
2019-12-31NZ$93.27 B-6.44%
2018-12-31NZ$99.69 B20.31%
2017-12-31NZ$82.86 B3.92%
2016-12-31NZ$79.73 B0.26%
2015-12-31NZ$79.53 B14.25%
2014-12-31NZ$69.61 B10.47%
2013-12-31NZ$63.01 B-5.63%
2012-12-31NZ$66.77 B1.08%
2011-12-31NZ$66.05 B-4.83%
2010-12-31NZ$69.41 B32.52%
2009-12-31NZ$52.37 B9.09%
2008-12-31NZ$48.01 B41.14%
2007-12-31NZ$34.01 B-10.29%
2006-12-31NZ$37.91 B5.49%
2005-12-31NZ$35.94 B21.14%
2004-12-31NZ$29.67 B2.61%
2003-12-31NZ$28.91 B-9.32%
2002-12-31NZ$31.89 B-10.2%
2001-12-31NZ$35.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merck
MRK
NZ$134.26 B 24.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$199.96 B 84.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.34 B 81.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$114.18 B 5.58%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$105.97 B-2.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$56.37 B-47.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
NZ$135.38 B 25.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$56.92 B-47.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.43 B 9.51%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com